1. Home
  2. ETNB
  3. ETNB News

Latest 89bio Inc. (ETNB) News on March 14, 2025

ETNB

MT Newswires

a day ago

Citigroup Initiates 89bio Inc at Buy With $25 Price Target

Bears are Losing Control Over 89BIO (ETNB), Here's Why It's a 'Buy' Now
ETNB

Zacks

2 days ago

Bears are Losing Control Over 89BIO (ETNB), Here's Why It's a 'Buy' Now

89bio to Participate in the Leerink Partners Global Healthcare Conference
ETNB

GlobeNewswire

11 days ago

89bio to Participate in the Leerink Partners Global Healthcare Conference

89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates
ETNB

GlobeNewswire

15 days ago

89bio Reports Fourth Quarter and Full Year 2024 Financial Results and Corporate Updates

ETNB

Argus Research

21 days ago

Daily – Vickers Top Insider Picks for 02/21/2025

Wall Street Analysts See a 171.42% Upside in 89BIO (ETNB): Can the Stock Really Move This High?
ETNB

Zacks

22 days ago

Wall Street Analysts See a 171.42% Upside in 89BIO (ETNB): Can the Stock Really Move This High?

Should You Buy 89BIO (ETNB) After Golden Cross?
ETNB

Zacks

22 days ago

Should You Buy 89BIO (ETNB) After Golden Cross?

Institutional investors have a lot riding on 89bio, Inc. (NASDAQ:ETNB) with 58% ownership
ETNB

Simply Wall St.

a month ago

Institutional investors have a lot riding on 89bio, Inc. (NASDAQ:ETNB) with 58% ownership

ETNB

MT Newswires

a month ago

89bio Closes $287.5 Million Public Offering

89bio Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
ETNB

GlobeNewswire

a month ago

89bio Announces Closing of its Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares

89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants
ETNB

GlobeNewswire

a month ago

89bio, Inc. Announces Pricing of $250.0 Million Public Offering of Common Stock and Pre-Funded Warrants

Why 89bio Stock Lagged the Market Today
ETNB

Motley Fool

a month ago

Why 89bio Stock Lagged the Market Today

89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
ETNB

GlobeNewswire

2 months ago

89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Akero Therapeutics Stock Doubles — Pulling 89bio Higher — On Positive MASH Study
ETNB

Investor's Business Daily

2 months ago

Akero Therapeutics Stock Doubles — Pulling 89bio Higher — On Positive MASH Study

ETNB

Argus Research

2 months ago

Daily – Vickers Top Buyers & Sellers for 01/24/2025

89bio Provides Business Update and Outlook for 2025
ETNB

GlobeNewswire

2 months ago

89bio Provides Business Update and Outlook for 2025

New Strong Sell Stocks for January 7th
ETNB

Zacks

2 months ago

New Strong Sell Stocks for January 7th

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ETNB

GlobeNewswire

3 months ago

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Why Is 89bio, Inc. (ETNB) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?
ETNB

Insider Monkey

3 months ago

Why Is 89bio, Inc. (ETNB) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds?

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ETNB

GlobeNewswire

3 months ago

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

89bio to Participate in the 7th Annual Evercore HealthCONx Conference
ETNB

GlobeNewswire

4 months ago

89bio to Participate in the 7th Annual Evercore HealthCONx Conference

89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting® 2024
ETNB

GlobeNewswire

4 months ago

89bio Presents New Analyses Evaluating Pegozafermin and Potential Benefit of Non-Invasive Tests from the ENLIVEN Phase 2b Trial in MASH Patients at AASLD The Liver Meeting® 2024

89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants
ETNB

GlobeNewswire

4 months ago

89bio, Inc. Announces Upsized Pricing of $125.0 Million Public Offering of Common Stock and Pre-Funded Warrants

89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants
ETNB

GlobeNewswire

4 months ago

89bio, Inc. Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants

89bio Reports Third Quarter 2024 Financial Results and Corporate Updates
ETNB

GlobeNewswire

4 months ago

89bio Reports Third Quarter 2024 Financial Results and Corporate Updates

89bio to Participate in the UBS Global Healthcare Conference
ETNB

GlobeNewswire

4 months ago

89bio to Participate in the UBS Global Healthcare Conference

Madrigal, 89Bio jump after Novo’s semaglutide shows promise in MASH
ETNB

TipRanks

4 months ago

Madrigal, 89Bio jump after Novo’s semaglutide shows promise in MASH

Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH
ETNB

Investor's Business Daily

4 months ago

Madrigal Catapults After Novo's Wegovy Proves It's No 'Silver Bullet' In MASH

Suvretta Capital Management's Strategic Reduction in 89bio Inc Holdings
ETNB

GuruFocus.com

5 months ago

Suvretta Capital Management's Strategic Reduction in 89bio Inc Holdings

State Street Corp's Strategic Acquisition in 89bio Inc
ETNB

GuruFocus.com

5 months ago

State Street Corp's Strategic Acquisition in 89bio Inc

89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at AASLD The Liver Meeting® 2024
ETNB

GlobeNewswire

5 months ago

89bio to Present New Analyses from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at AASLD The Liver Meeting® 2024

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ETNB

GlobeNewswire

5 months ago

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

89bio to Participate in the H.C. Wainwright 8th Annual MASH Investor Conference
ETNB

GlobeNewswire

5 months ago

89bio to Participate in the H.C. Wainwright 8th Annual MASH Investor Conference

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ETNB

GlobeNewswire

6 months ago

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ETNB

MT Newswires

6 months ago

89bio Appoints Teresa Perney as Chief Regulatory, Quality Officer

89bio Announces Appointment of Teresa Perney, Ph.D. as Chief Regulatory and Quality Officer
ETNB

GlobeNewswire

6 months ago

89bio Announces Appointment of Teresa Perney, Ph.D. as Chief Regulatory and Quality Officer

89bio to Participate in Upcoming Investor Conferences
ETNB

GlobeNewswire

6 months ago

89bio to Participate in Upcoming Investor Conferences

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ETNB

GlobeNewswire

7 months ago

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ETNB

MT Newswires

7 months ago

89bio Names Francis Sarena Chief Operating Officer

89bio Appoints Francis Sarena as Chief Operating Officer
ETNB

GlobeNewswire

7 months ago

89bio Appoints Francis Sarena as Chief Operating Officer

89bio Appoints Charles McWherter, Ph.D., to its Board of Directors
ETNB

GlobeNewswire

7 months ago

89bio Appoints Charles McWherter, Ph.D., to its Board of Directors

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ETNB

GlobeNewswire

8 months ago

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ETNB

GlobeNewswire

9 months ago

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

89bio to Present 48-Week Data from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at EASL International Liver Congress
ETNB

GlobeNewswire

10 months ago

89bio to Present 48-Week Data from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at EASL International Liver Congress

89bio Initiates Phase 3 ENLIGHTEN-Cirrhosis Trial of Pegozafermin in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Patients with Compensated Cirrhosis
ETNB

GlobeNewswire

10 months ago

89bio Initiates Phase 3 ENLIGHTEN-Cirrhosis Trial of Pegozafermin in Metabolic Dysfunction-Associated Steatohepatitis (MASH) Patients with Compensated Cirrhosis

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ETNB

GlobeNewswire

10 months ago

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

ETNB

GuruFocus.com

10 months ago

89bio Inc (ETNB) Reports Increased Losses in Q1 2024 Despite Advancements in Clinical Trials

89bio Reports First Quarter 2024 Financial Results and Provides Corporate Update
ETNB

GlobeNewswire

10 months ago

89bio Reports First Quarter 2024 Financial Results and Provides Corporate Update

‘Jump on the Bandwagon,’ Says Bank of America About These 2 Stock Picks
ETNB

TipRanks

10 months ago

‘Jump on the Bandwagon,’ Says Bank of America About These 2 Stock Picks

89bio to Participate in the BofA Securities 2024 Health Care Conference
ETNB

GlobeNewswire

10 months ago

89bio to Participate in the BofA Securities 2024 Health Care Conference

89bio to Host Key Opinion Leader Webinar on Pegozafermin’s Opportunity in Advanced MASH
ETNB

GlobeNewswire

10 months ago

89bio to Host Key Opinion Leader Webinar on Pegozafermin’s Opportunity in Advanced MASH

89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors
ETNB

GlobeNewswire

a year ago

89bio Appoints Biotech Industry Veteran, Martin Babler to its Board of Directors

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ETNB

GlobeNewswire

a year ago

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

89bio Inc CEO Rohan Palekar Sells 52,718 Shares
ETNB

GuruFocus.com

a year ago

89bio Inc CEO Rohan Palekar Sells 52,718 Shares

89bio Receives EMA PRIME Status for Pegozafermin in the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Fibrosis and Compensated Cirrhosis
ETNB

GlobeNewswire

a year ago

89bio Receives EMA PRIME Status for Pegozafermin in the Treatment of Metabolic Dysfunction-Associated Steatohepatitis (MASH) with Fibrosis and Compensated Cirrhosis

Ozempic Can’t Do It All—A Potential New Blockbuster Is a Reminder of That
ETNB

The Wall Street Journal

a year ago

Ozempic Can’t Do It All—A Potential New Blockbuster Is a Reminder of That

13 Best Biotech Stocks To Buy Under $20
ETNB

Insider Monkey

a year ago

13 Best Biotech Stocks To Buy Under $20

89bio Initiates Phase 3 ENLIGHTEN-Fibrosis Trial of Pegozafermin in Non-Cirrhotic Metabolic Dysfunction-Associated Steatohepatitis (MASH) Patients with Fibrosis
ETNB

GlobeNewswire

a year ago

89bio Initiates Phase 3 ENLIGHTEN-Fibrosis Trial of Pegozafermin in Non-Cirrhotic Metabolic Dysfunction-Associated Steatohepatitis (MASH) Patients with Fibrosis

89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
ETNB

GlobeNewswire

a year ago

89bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

89bio to Participate in the Leerink Partners Global Biopharma Conference
ETNB

GlobeNewswire

a year ago

89bio to Participate in the Leerink Partners Global Biopharma Conference

Akero (AKRO) Up on Upbeat Week 96 Data From Liver Disease Study
ETNB

Zacks

a year ago

Akero (AKRO) Up on Upbeat Week 96 Data From Liver Disease Study

Wall Street Analysts Believe 89BIO (ETNB) Could Rally 121.5%: Here's is How to Trade
ETNB

Zacks

a year ago

Wall Street Analysts Believe 89BIO (ETNB) Could Rally 121.5%: Here's is How to Trade

89BIO (ETNB) Just Overtook the 200-Day Moving Average
ETNB

Zacks

a year ago

89BIO (ETNB) Just Overtook the 200-Day Moving Average

Why Akero Rocketed — And Pulled Rival 89bio Higher — On Results In Liver Disease Treatment
ETNB

Investor's Business Daily

a year ago

Why Akero Rocketed — And Pulled Rival 89bio Higher — On Results In Liver Disease Treatment

Data Suggests Makers of Fatty Liver Treatments Won’t Be Displaced by Obesity Drugs
ETNB

The Wall Street Journal

a year ago

Data Suggests Makers of Fatty Liver Treatments Won’t Be Displaced by Obesity Drugs

Akero Rockets 27%, Prodding Rival 89bio Higher, On Promising Liver Disease Treatment
ETNB

Investor's Business Daily

a year ago

Akero Rockets 27%, Prodding Rival 89bio Higher, On Promising Liver Disease Treatment

ETNB

GuruFocus.com

a year ago

89bio Inc (ETNB) Reports Increased R&D Spend and Strengthened Cash Position in Q4 and Full ...

89bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
ETNB

GlobeNewswire

a year ago

89bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates

11 Best Small-Cap Growth Stocks to Invest In
ETNB

Insider Monkey

a year ago

11 Best Small-Cap Growth Stocks to Invest In

89bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference
ETNB

GlobeNewswire

a year ago

89bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
ETNB

GlobeNewswire

a year ago

89bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Purdy on how SF's experience with 'backs against wall' helps in adversity
ETNB

NFL Highlights

a year ago

Purdy on how SF's experience with 'backs against wall' helps in adversity

Ramaco Announces Hiring of Distinguished West Virginian as New General Counsel; First Quarter 2024 Class B Dividend Declared
ETNB

PR Newswire

a year ago

Ramaco Announces Hiring of Distinguished West Virginian as New General Counsel; First Quarter 2024 Class B Dividend Declared

ETNB

Associated Press Finance

a year ago

MaxLinear: Q4 Earnings Snapshot

The Cheesecake Factory to Webcast Fourth Quarter Fiscal 2023 Earnings Conference Call on February 21, 2024
ETNB

Business Wire

a year ago

The Cheesecake Factory to Webcast Fourth Quarter Fiscal 2023 Earnings Conference Call on February 21, 2024

MaxLinear, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results
ETNB

Business Wire

a year ago

MaxLinear, Inc. Announces Fourth Quarter and Fiscal Year 2023 Financial Results

Star Bulk Carriers Stock Sees RS Rating Improve To 71
ETNB

Investor's Business Daily

a year ago

Star Bulk Carriers Stock Sees RS Rating Improve To 71

Star Bulk Carriers (SBLK) Advances While Market Declines: Some Information for Investors
ETNB

Zacks

a year ago

Star Bulk Carriers (SBLK) Advances While Market Declines: Some Information for Investors

Apogee Enterprises Announces Strategic Actions to Reduce Costs and Strengthen the Company’s Position for Profitable Growth
ETNB

Business Wire

a year ago

Apogee Enterprises Announces Strategic Actions to Reduce Costs and Strengthen the Company’s Position for Profitable Growth

The Zacks Analyst Blog Highlights Silicon Motion Technology, NVIDIA, Allegro MicroSystems and Ambarella
ETNB

Zacks

a year ago

The Zacks Analyst Blog Highlights Silicon Motion Technology, NVIDIA, Allegro MicroSystems and Ambarella

Kodiak Gas Services Announces Launch of $750 Million Senior Unsecured Notes Offering
ETNB

PR Newswire

a year ago

Kodiak Gas Services Announces Launch of $750 Million Senior Unsecured Notes Offering

ETNB

Associated Press Finance

a year ago

First Financial: Q4 Earnings Snapshot

First Financial Bancorp (FFBC) Reports Solid Loan Growth Amid Rising Funding Costs
ETNB

GuruFocus.com

a year ago

First Financial Bancorp (FFBC) Reports Solid Loan Growth Amid Rising Funding Costs

First Bancorp (FBNC) Reports Mixed Results Amidst GrandSouth Acquisition
ETNB

GuruFocus.com

a year ago

First Bancorp (FBNC) Reports Mixed Results Amidst GrandSouth Acquisition

First Busey (BUSE) Tops Q4 Earnings and Revenue Estimates
ETNB

Zacks

a year ago

First Busey (BUSE) Tops Q4 Earnings and Revenue Estimates

Procter & Gamble (PG) Beats Q2 Earnings Estimates, Ups EPS View
ETNB

Zacks

a year ago

Procter & Gamble (PG) Beats Q2 Earnings Estimates, Ups EPS View

Best Income Stocks to Buy for January 23rd
ETNB

Zacks

a year ago

Best Income Stocks to Buy for January 23rd

Best Value Stocks to Buy for January 23rd
ETNB

Zacks

a year ago

Best Value Stocks to Buy for January 23rd

ETNB

Investing.com

a year ago

Coinbase Global cut at JPMorgan amid Bitcoin ETF skepticism: 4 big analyst cuts

ETNB

Associated Press Finance

a year ago

Banner: Q4 Earnings Snapshot

Banner Corporation Reports Net Income of $42.6 Million, or $1.24 Per Diluted Share, for 4th Quarter 2023; Earns $183.6 Million in Net Income, or $5.33 Per Diluted Share, for the Full Year of 2023; Declares Quarterly Cash Dividend of $0.48 Per Share
ETNB

Business Wire

a year ago

Banner Corporation Reports Net Income of $42.6 Million, or $1.24 Per Diluted Share, for 4th Quarter 2023; Earns $183.6 Million in Net Income, or $5.33 Per Diluted Share, for the Full Year of 2023; Declares Quarterly Cash Dividend of $0.48 Per Share

Manufacturing Marvels: 3 Industrial Stocks Set for Success
ETNB

InvestorPlace

a year ago

Manufacturing Marvels: 3 Industrial Stocks Set for Success

Industry-First Center-Mounted Twin-Engine Barletta Pontoon Boat Honored with Innovation Award at Minneapolis Boat Show
ETNB

GlobeNewswire

a year ago

Industry-First Center-Mounted Twin-Engine Barletta Pontoon Boat Honored with Innovation Award at Minneapolis Boat Show

89BIO (ETNB) Recently Broke Out Above the 20-Day Moving Average
ETNB

Zacks

a year ago

89BIO (ETNB) Recently Broke Out Above the 20-Day Moving Average

ETNB

Business Wire

a year ago

Sonos Announces Date for First Quarter Fiscal 2024 Financial Results and Conference Call

Winnebago Industries Announces Proposed Private Offering of $300 Million of Convertible Senior Notes
ETNB

GlobeNewswire

a year ago

Winnebago Industries Announces Proposed Private Offering of $300 Million of Convertible Senior Notes

MaxLinear, Inc. Announces Conference Call to Review Fourth Quarter and Fiscal Year 2023 Financial Results
ETNB

Business Wire

a year ago

MaxLinear, Inc. Announces Conference Call to Review Fourth Quarter and Fiscal Year 2023 Financial Results

What Does Sonos, Inc.'s (NASDAQ:SONO) Share Price Indicate?
ETNB

Simply Wall St.

a year ago

What Does Sonos, Inc.'s (NASDAQ:SONO) Share Price Indicate?

Mawson Infrastructure Group Inc. Announces Monthly Operational Update for December 2023
ETNB

GlobeNewswire

a year ago

Mawson Infrastructure Group Inc. Announces Monthly Operational Update for December 2023

Summit's (SUM) Shareholders Approve Merger With Argos USA
ETNB

Zacks

a year ago

Summit's (SUM) Shareholders Approve Merger With Argos USA

Share on Social Networks: